Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook



 

Gene therapy repairs heart attack damage

27 August 2013

By Lanay Tierney

Appeared in BioNews 719

Researchers have concocted a 'gene cocktail' that may help to turn scar tissue into functioning cardiac cells after a heart attack.

Scar tissue often forms following a heart attack in the area that was most affected. The result is a decreased ability of the heart to beat properly and can eventually lead to heart failure. The scientists, from the Gladstone Institutes in San Francisco, USA, are working with cells called fibroblasts, which make up about half of all heart cells. They are aiming to reprogram the function of these fibroblasts from primarily providing structural support to beating heart cells by injecting a cocktail of genes.

In 2012 the team found that by directly injecting three cardiac genes, collectively referred to as GMT, they observed decreased scar size and improved cardiac function in mice. In this study, they tested this procedure on human cells, but found that using the same GMT combination in human fibroblasts was not enough.

'When we injected GMT into each of the three types of human fibroblasts, nothing happened - they never transformed - so we went back to the drawing board to look for additional genes that would help initiate the transformation. We narrowed our search to just 16 potential genes, which we then screened alongside GMT, in the hopes that we could find the right combination', explained lead author Dr Ji-dong Fu.

The authors were able to identify four additional genes that, together with GMT, promoted reprogramming in human fibroblast cells. With the addition of these genes, around 20 percent of all treated cells could then function like beating heart cells, including being able to transmit electrical signals.

Within the UK, around 750,000 people have heart muscle that is severely damaged by a heart attack and are at risk for heart failure. It is estimated that within five years this damage will kill three-quarters of patients affected. Finding a way to improve treatment of this damaged tissue could eventually improve patient outcome long term.

The findings of this study are a proof of the concept that human fibroblasts have the ability to be reprogrammed into beating heart cells. However more research will be needed to make the process more efficient.

Professor Jeremy Pearson, Associate Medical Director at the British Heart Foundation told The Telegraph that 'this research represents a small but significant step forward'.

SOURCES & REFERENCES
Stem Cell Reports | 22 August 2013
 
Gladstone Institutes (press release) | 22 August 2013
 
Daily Telegraph | 22 August 2013
 
The Independent | 22 August 2013
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

15 December 2014 - by Dr Molly Godfrey 
Scientists have identified a set of rare gene mutations that may increase the risk of early heart attacks...
16 June 2014 - by Dr Kimberley Bryon-Dodd 
Genes linked to cholesterol levels have been successfully edited in mice who received a single injection, thereby reducing their risk of heart disease, according to a study...
06 May 2014 - by Dr Rachael Panizzo 
Heart cells derived from human embryonic stem cells are capable of regenerating damaged heart muscle in primates, a US study has found...
18 November 2013 - by Siobhan Chan 
Heart failure can be reversed using gene therapy, with the effect being amplified when two genes are used together, a study in pigs has found...
09 September 2013 - by Siobhan Chan 
The first patients from two separate ongoing studies have been treated using gene and stem cell therapies to repair damage caused by heart attacks...

19 August 2013 - by Dr Katie Howe 
A mouse heart was able to contract again after its own cells were removed and replaced with human stem cells, a study in Nature Communications reports...
22 July 2013 - by Dr Katie Howe 
Human stem cells have been used to create networks of blood vessels in mice that functioned for nine months...
07 May 2013 - by Siobhan Chan 
Gene therapy will be used to treat heart failure for the first time in the UK, in clinical trials being launched by the British Heart Foundation...
22 April 2013 - by Emma Stoye 
Researchers have identified a gene that regulates the regeneration of adult heart cells...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation